T. Rowe Price Associates’s Immuneering IMRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-659,009
| Closed | -$1M | – | 3095 |
|
|
2025
Q1 | $1M | Sell |
659,009
-108,115
| -14% | -$164K | ﹤0.01% | 1957 |
|
|
2024
Q4 | $1.69M | Sell |
767,124
-43,003
| -5% | -$94.6K | ﹤0.01% | 1718 |
|
|
2024
Q3 | $2.02M | Sell |
810,127
-49,247
| -6% | -$123K | ﹤0.01% | 1633 |
|
|
2024
Q2 | $1.1M | Sell |
859,374
-50,892
| -6% | -$65.1K | ﹤0.01% | 1857 |
|
|
2024
Q1 | $2.63M | Sell |
910,266
-2,467,834
| -73% | -$7.14M | ﹤0.01% | 1445 |
|
|
2023
Q4 | $24.8M | Sell |
3,378,100
-155,222
| -4% | -$1.14M | ﹤0.01% | 900 |
|
|
2023
Q3 | $27.1M | Sell |
3,533,322
-47,423
| -1% | -$364K | ﹤0.01% | 842 |
|
|
2023
Q2 | $36.3M | Buy |
3,580,745
+122,377
| +4% | +$1.24M | 0.01% | 788 |
|
|
2023
Q1 | $33.6M | Sell |
3,458,368
-161,192
| -4% | -$1.57M | 0.01% | 788 |
|
|
2022
Q4 | $17.6M | Sell |
3,619,560
-43,932
| -1% | -$213K | ﹤0.01% | 944 |
|
|
2022
Q3 | $52.5M | Sell |
3,663,492
-479,337
| -12% | -$6.86M | 0.01% | 632 |
|
|
2022
Q2 | $22.4M | Buy |
4,142,829
+577,356
| +16% | +$3.12M | ﹤0.01% | 1135 |
|
|
2022
Q1 | $23.1M | Buy |
3,565,473
+376,968
| +12% | +$2.44M | ﹤0.01% | 1195 |
|
|
2021
Q4 | $50.7M | Buy |
3,188,505
+74,480
| +2% | +$1.18M | ﹤0.01% | 1002 |
|
|
2021
Q3 | $81.2M | Buy |
+3,114,025
| New | +$81.2M | 0.01% | 835 |
|